Pyxis Oncology, Inc. (NASDAQ:PYXS) counted 76 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.
| # | Institution | CIK | Shares Held | % of Outstanding | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|---|---|
| 1 | GordonMD Global Investments LP | 0002039349 | 10,024,909 | 15.67% | ▲5,903,039 | +143.21% | $30.17Mn |
| 2 | Pfizer Inc | 0000078003 | 7,032,770 | 10.99% | 0 | 0.00% | $19.48Mn |
| 3 | Laurion Capital Management LP | 0001390202 | 4,900,888 | 7.66% | ▼96,445 | -1.93% | $14.75Mn |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 0002100119 | 2,075,997 | 3.24% | ▲42,487 | +2.09% | $6.25Mn |
| 5 | Atle Fund Management AB | 0001381843 | 966,459 | 1.51% | ▲769,423 | +390.50% | $2.91Mn |
| 6 | BlackRock, Inc. | 0002012383 | 867,934 | 1.36% | ▲79,095 | +10.03% | $2.61Mn |
| 7 | Palo Alto Investors LP | 0001306923 | 864,277 | 1.35% | ▼146,233 | -14.47% | $2.60Mn |
| 8 | MARSHALL WACE, LLP | 0001318757 | 830,544 | 1.30% | ▲476,127 | +134.34% | $2.50Mn |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 0001037389 | 772,232 | 1.21% | ▼116,448 | -13.10% | $2.32Mn |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0001214717 | 591,849 | 0.92% | ▼6,272 | -1.05% | $1.78Mn |
| 11 | Woodline Partners LP | 0001784547 | 523,999 | 0.82% | ▲523,999 | 0.00% | $1.58Mn |
| 12 | 683 Capital Management, LLC | 0001404574 | 459,367 | 0.72% | ▼436,896 | -48.75% | $1.38Mn |
| 13 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0000884414 | 428,606 | 0.67% | ▼32,391 | -7.03% | $1.29Mn |
| 14 | Longaeva Partners L.P. | 0002054122 | 353,582 | 0.55% | ▼149,632 | -29.74% | $1.06Mn |
| 15 | Decheng Capital LLC | 0002010850 | 326,810 | 0.51% | 0 | 0.00% | $983.70K |
| 16 | VANGUARD FIDUCIARY TRUST CO | 0000933478 | 302,986 | 0.47% | ▲2,089 | +0.69% | $911.99K |
| 17 | JANE STREET GROUP, LLC | 0001595888 | 290,090 | 0.45% | ▼14,369 | -4.72% | $873.17K |
| 18 | State Street Corp | 0000093751 | 248,837 | 0.39% | 0 | 0.00% | $749.00K |
| 19 | MILLENNIUM MANAGEMENT LLC | 0001273087 | 233,004 | 0.36% | ▼164,621 | -41.40% | $701.34K |
| 20 | UBS Group AG | 0001610520 | 155,217 | 0.24% | ▼98,907 | -38.92% | $467.20K |